Is there a roadmap for relapsed neuroblastoma?
There is not a specific roadmap for relapsed neuroblastoma, as the therapy depends on the timing of the relapse in relation to prior therapy, the initial stage and treatment, the biology of the disease and pace of the disease. In general, for a first relapse one would apply therapies that are approved and tested that the patient has not had, either as part of a phase II trial or as standard of care. For subsequent relapse, it is appropriate to enter a phase I or II clinical trial, with the choice dependent again on many of the factors mentioned above.
